Isolation, infectious: Difference between revisions
No edit summary |
|||
| (11 intermediate revisions by 2 users not shown) | |||
| Line 23: | Line 23: | ||
**reverse isolation -- i.e. a person at risk for getting infection (e.g. neutropenic after chemotherapy for cancer) is isolated to try and avoid them being exposed | **reverse isolation -- i.e. a person at risk for getting infection (e.g. neutropenic after chemotherapy for cancer) is isolated to try and avoid them being exposed | ||
**cohorting the patient with other patients with the same [[Pathogens|pathogen]] | **cohorting the patient with other patients with the same [[Pathogens|pathogen]] | ||
**use for those AGMP's that are continuous e.g. BIPAP, CPAP, Optiflow . As of May10,2023 only those patients designated as "orange", or "red" require isolation/PPE precautions. "green" patients have no special precautions. Do not use for one time AGMP's where there is no other indication for isolation. e.g intubation, bronchoscopy, CPR, nebulizer medications | |||
<!-- discussed inconsistency with Optiflow being included here but not else; yes it is correct that it is excluded elsewhere and included here - discussed at task. 2022-06-22 --> | |||
=== In the context of [[Colonized with organism (not infected)]] === | === In the context of [[Colonized with organism (not infected)]] === | ||
| Line 43: | Line 45: | ||
== Data use == | == Data use == | ||
* [[Directors Annual Report (Medicine) | * [[Directors Quarterly and Annual Report (Medicine)|Directors Quarterly and Annual Report]] | ||
== Related Articles == | == Related Articles == | ||